Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Orelabrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (OFCG) for First-Line Treatment of Chronic Lymphocytic Leukemia: A Multicenter, Investigator-Initiated Study (cwCLL-001 Study)

Huayuan Zhu, Yi Miao, Shuchao Qin, Ming Liu, Yi Xia, Luomengjia Dai, Tonglu Qiu, Chong-Yang Ding, Hairong Qiu, Chun Qiao, Yujie Wu, Fei Li, Xiao Lu, Wei Xu, Lei Fan, Jianyong Li

Blood (2024) 144 (Supplement 1): 3244.

https://doi.org/10.1182/blood-2024-204881

Published: 2024

Journal Articles

Orelabrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (OFCG) for First-Line Treatment of Chronic Lymphocytic Leukemia: A Multicenter, Investigator-Initiated Study (cwCLL-001 Study)

Huayuan Zhu, Yi Miao, Yi Xia, Shuchao Qin, Wei Wu, Tonglu Qiu, Chong-Yang Ding, Hairong Qiu, Chun Qiao, Yujie Wu, Fei Li, Wei Xu, Jianyong Li

Blood (2023) 142 (Supplement 1): 4642.

https://doi.org/10.1182/blood-2023-188925

Published: 2023

Journal Articles

Prospective Self-Control Analysis of Glucocorticoid Maintenance Therapy for Paroxysmal Nocturnal Hemoglobinuria

Hui Yang, Yuemin Gong, Ruixin Li, Chun Qiao, Run Zhang, Guangsheng He, Jianyong Li

Blood (2022) 140 (Supplement 1): 11455–11456.

https://doi.org/10.1182/blood-2022-166197

Published: 2022

Journal Articles

Cyclophosphamide Combined with Prednisone for Cyclosporine-Refractory/Relapsed Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia

Xiaoqing Liu, Qiqiang Long, Xi Chen, Chun Qiao, Guangsheng He, Shengyun Lin, Jianyong Li

Blood (2022) 140 (Supplement 1): 2926–2927.

https://doi.org/10.1182/blood-2022-168600

Published: 2022

Journal Articles

Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As the Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia: A Single-Center Real World Study

Huayuan Zhu, Hui Shen, Yilian Yang, Chong-Yang Ding, MD, Yeqin Sha, Hongling Mi, Jingyan Qiu, Ruize Chen, Yujie Wu, Chun Qiao, Li Wang, MD, Lei Fan, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-141747

Published: 2020

Journal Articles

Genomic Landscape of Chinese Patients with Chronic Lymphocytic Leukemia By Whole-Exome Sequencing

Yi Miao, MD PhD, Yi Xia, Chun Qiao, Huayuan Zhu, Jiazhu Wu, MD, Hui Jin, Jianxin Fu, MD PhD, Li Wang, MD, Lei Fan, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 2784.

https://doi.org/10.1182/blood-2019-127813

Published: 2019

Journal Articles

TP53 Abnormality in Myelodysplastic Syndrome

Fei Huang, Yu Chen, Yuxing Zhu, Chun Qiao, Sixuan Qian, Jianyong Li, MD, Wenyi Shen, MD

Blood (2019) 134 (Supplement_1): 5410.

https://doi.org/10.1182/blood-2019-128054

Published: 2019

Journal Articles

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

Hua Yin, Suli Wang, Xingyu Lu, Wenyi Shen, MD, Ruinan Lu, Yu Zhu, MD PhD, Kourong Miao, Ming Hong, MD PhD, Shuai Wang, MD PhD, Jianfu Zhang, Chun Qiao, Yujie Wu, Xuemei Wu, Guangsheng He, Jianyong Li, MD PhD

Blood (2018) 132 (Supplement 1): 5107.

https://doi.org/10.1182/blood-2018-99-118836

Published: 2018

Journal Articles

98% IGHV Gene Identity Is Still the Optimal Cutoff to Predict the Prognosis of Chronic Lymphocytic Leukemia Patients in China

Yi Xia, Ke Shi, Qian Sun, Chun Qiao, Huayuan Zhu, Li Wang, MD, Lei Fan, MD PhD, Wei Xu, Jianyong Li, MD PhD

Blood (2018) 132 (Supplement 1): 5545.

https://doi.org/10.1182/blood-2018-99-118141

Published: 2018

Journal Articles

PFKFB3 Is a Crucial Target in the Treatment of Tyrosine Kinase Inhibitor Resistant Chronic Myelogenous Leukemia

Yu Zhu, Jianyong Li, Chun Qiao, Yi Shan, MD, Sixuan Qian, Yaoyu Chen, Ming Hong, Huihui Zhao, Huapeng LI, Xuejun Zhu, Yang Zhongfa

Blood (2016) 128 (22): 3936.

https://doi.org/10.1182/blood.V128.22.3936.3936

Published: 2016

Journal Articles

Clinical Significance of CSF3R , SRSF2 and SETBP1 mutation in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia

Chun Qiao, Yuan Ouyang, Sujiang Zhang

Blood (2015) 126 (23): 1617.

https://doi.org/10.1182/blood.V126.23.1617.1617

Published: 2015

Journal Articles

Chinese External Validation of the Cochrane Haematological Malignancies Group Prognostic Index for Chronic Lymphocytic Leukemia Patients

Shu Chao Qin, Wei Xu, Yi Xia, Chun Qiao, Lei Fan, MD, PhD, Li Wang, Yao Yu Chen, Jianyong Li, MD PhD

Blood (2015) 126 (23): 5280.

https://doi.org/10.1182/blood.V126.23.5280.5280

Published: 2015

Journal Articles

Characteristics and Prognostic Significance of CRLF2 High Expression and the Co-Existence with JAK1 Mutations and Ikaros Deletion in Adult Acute Lymphoblastic Leukemia

Zheng Ge, MD, PhD, Juan Liu, Run Zhang, MD, Xing Guo, Jing-Yan Xu, Min Li, Chun Qiao, Jian-Yong Li, MD PhD

Blood (2014) 124 (21): 3800.

https://doi.org/10.1182/blood.V124.21.3800.3800

Published: 2014

Journal Articles

The clinical significance of STAT3 mutation, LDH and β2-MG in T-cell large granular lymphocytic Leukemia

Zhi-Yuan Qiu, M.D., Lei Fan, M.D., Li Wang, M.D., Chun Qiao, Yu-Jie Wu, Jian-Feng Zhou, MD, PhD, Wei Xu, MD, PhD, Jian-Yong Li, MD, PhD

Blood (2013) 122 (21): 3483.

https://doi.org/10.1182/blood.V122.21.3483.3483

Published: 2013

Journal Articles

Distinct IGHV Repertoire Features In Chinese Chronic Lymphocytic Leukemia Patients

Yi Xia, MD., Wei Xu, MD, PhD, Lei Fan, MD, PhD, Chun Qiao, Li Wang, MD., Ji Xu, MD., Man Wang, MD., Jian-Yong Li, MD, PhD

Blood (2013) 122 (21): 5279.

https://doi.org/10.1182/blood.V122.21.5279.5279

Published: 2013

Journal Articles

Clinical Significance of Notch1 Mutation in Chinese B-CLL Patients,

Wenyi Shen, Peng Liu, Chun Qiao, Jianyong Li, MD, PhD

Blood (2011) 118 (21): 3892.

https://doi.org/10.1182/blood.V118.21.3892.3892

Published: 2011

Journal Articles

Research on the Characteristics of IGHV Gene In Chronic Lymphocytic Leukemia of China.

Chun Qiao, Kourong Miao, Jianyong Li, MD, PhD

Blood (2010) 116 (21): 4609.

https://doi.org/10.1182/blood.V116.21.4609.4609

Published: 2010

Journal Articles

Rituximab Combining with Fresh Frozen Plasma for the Treatment of Patients with Refractory Advanced CLL.

Wei Xu, MD, PhD, Jianyong Li, MD, PhD, Kourong Miao, Ming Hong, Chun Qiao, Yu-Jie Wu, Lei Fan, Peng Liu

Blood (2009) 114 (22): 3450.

https://doi.org/10.1182/blood.V114.22.3450.3450

Published: 2009

Journal Articles

Prognostic Factors of Chinese Patients with Chronic Lymphocytic Leukemia.

Jianyong Li, MD, PhD, Wei Xu, MD, PhD, Chun Qiao, Yu-Jie Wu, Kourong Miao, Lei Fan, Peng Liu

Blood (2009) 114 (22): 4387.

https://doi.org/10.1182/blood.V114.22.4387.4387

Published: 2009

Journal Articles

The Prognostic Significance of Positive Direct Antiglobulin Test in Chinese Patients with Chronic Lymphocytic Leukemia

Wei Xu, MD, PhD, Jianyong Li, MD, PhD, Xin Cao, DAN-Xia Zhu, Lin Yao, Qiong Liu, Chun Qiao, Yu-Jie Wu

Blood (2008) 112 (11): 4183.

https://doi.org/10.1182/blood.V112.11.4183.4183

Published: 2008

NARROW

Orelabrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (OFCG) for First-Line Treatment of Chronic Lymphocytic Leukemia: A Multicenter, Investigator-Initiated Study (cwCLL-001 Study)

Orelabrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (OFCG) for First-Line Treatment of Chronic Lymphocytic Leukemia: A Multicenter, Investigator-Initiated Study (cwCLL-001 Study)

Prospective Self-Control Analysis of Glucocorticoid Maintenance Therapy for Paroxysmal Nocturnal Hemoglobinuria

Cyclophosphamide Combined with Prednisone for Cyclosporine-Refractory/Relapsed Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia

Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As the Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia: A Single-Center Real World Study

Genomic Landscape of Chinese Patients with Chronic Lymphocytic Leukemia By Whole-Exome Sequencing

TP53 Abnormality in Myelodysplastic Syndrome

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

98% IGHV Gene Identity Is Still the Optimal Cutoff to Predict the Prognosis of Chronic Lymphocytic Leukemia Patients in China

PFKFB3 Is a Crucial Target in the Treatment of Tyrosine Kinase Inhibitor Resistant Chronic Myelogenous Leukemia

Clinical Significance of CSF3R , SRSF2 and SETBP1 mutation in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia

Chinese External Validation of the Cochrane Haematological Malignancies Group Prognostic Index for Chronic Lymphocytic Leukemia Patients

Characteristics and Prognostic Significance of CRLF2 High Expression and the Co-Existence with JAK1 Mutations and Ikaros Deletion in Adult Acute Lymphoblastic Leukemia

The clinical significance of STAT3 mutation, LDH and β2-MG in T-cell large granular lymphocytic Leukemia

Distinct IGHV Repertoire Features In Chinese Chronic Lymphocytic Leukemia Patients

Clinical Significance of Notch1 Mutation in Chinese B-CLL Patients,

Research on the Characteristics of IGHV Gene In Chronic Lymphocytic Leukemia of China.

Rituximab Combining with Fresh Frozen Plasma for the Treatment of Patients with Refractory Advanced CLL.

Prognostic Factors of Chinese Patients with Chronic Lymphocytic Leukemia.

The Prognostic Significance of Positive Direct Antiglobulin Test in Chinese Patients with Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only